Dr. Elie Akl, the director of the AUB GRADE center, co-chaired the panel meeting for the development of the World Health Organization (WHO) guidance on clinical management of Crimean-Congo Haemorrhagic Fever (CCHF).
CCHF is one of the most widespread tick-borne diseases in humans and endemic in areas including the middle east and has a case-fatality rate between 10% and 40%. WHO has included CCHF in its list of priority pathogens for which urgent research and developmental action is required.
The panel meeting was co-hosted by the Robert Koch Institute in Germany and the WHO Experts Network Unit (formerly the Epidemic clinical Management Unit) and was held on April 4-5 in Berlin, Germany.
CCHF is one of the most widespread tick-borne diseases in humans and endemic in areas including the middle east and has a case-fatality rate between 10% and 40%. WHO has included CCHF in its list of priority pathogens for which urgent research and developmental action is required.
The panel meeting was co-hosted by the Robert Koch Institute in Germany and the WHO Experts Network Unit (formerly the Epidemic clinical Management Unit) and was held on April 4-5 in Berlin, Germany.
